What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
On May 14, 2026, Krensavage Asset Management disclosed it bought 241,245 shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) , an estimated $5.43 million trade based on quarterly average pricing. Acco…
Yahoo Finance — 30 May 2026
Text:
5
0
0
On May 14, 2026, Krensavage Asset Management disclosed it bought 241,245 shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) , an estimated $5.43 millio
Read Full Story at Yahoo Finance → Sources
📈 Markets & Finance
Sam Altman says OpenAI's top token spender uses 100 billion tokens a month — and they're not even the world leader
📈 Markets & Finance
Intel, AMD, Micron shares sink as Broadcom results spark semiconductor sector sell-off
📈 Markets & Finance
This Smart‑Money Legend Won Big on Intel. The Rest of His Portfolio Might Be Even More Revealing
📈 Markets & Finance
A new NJ bill would hand pet owners up to $900 in tax credits — and your state could be next
📈 Markets & Finance
Addressing Investor Transparency, Updates from Euronet Worldwide’s (EEFT) First Analyst Day in a Decade
📈 Markets & Finance
MGM Resorts stock jumps as Barry Diller's People Inc. makes bid to take over the company
